Contrast transcranial Doppler identifies right-to-left shunts in hemorrhagic telangiectasia
Article Thumbnail ImageMay 3, 2011 -- NEW YORK (Reuters Health) - Contrast transcranial Doppler (TCDc) may be an effective alternative to contrast transthoracic echocardiography (TTCE) in screening for right-to-left shunts in patients with hereditary hemorrhagic telangiectasia (HHT), according to a report in the May 1 issue of Stroke.
Member Sign In:
  MemberID or E-mail Address:
  Password:
(?)

New AuntMinnie.com Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • OnLine CMe/CE
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • "The prevalence of HHT in North America is estimated to be one in 5,000, so the number of HHT patients in Canada is estimated at 6,750 and in USA 62,000," Dr. Khurshid Khan from University of Alberta, Edmonton, Canada, told Reuters Health in an email.

    "TCD may become a good initial screening test to look for right-to-left shunt in a patient suspected to have HHT and especially in the follow-up of these patients with pulmonary AVMs (arteriovenous malformation) who undergo coiling."

    Dr. Khan and colleagues compared TTCE and TCDc for detecting right-to-left shunt in 12 patients with HHT who also underwent CT pulmonary studies to determine the presence of pulmonary arteriovenous malformations.

    TTCE identified right-to-left shunt in 10 of the 12 patients, including all four patients with pulmonary arteriovenous malformation on chest CT. TTCE was 100% sensitive and 25% specific in identifying pulmonary arteriovenous malformation.

    TCDc showed a right-to-left shunt in nine of the 12 patients and identified all four patients with pulmonary AVM. This approach had 100% sensitivity and 37.5% specificity in detecting pulmonary AVM.

    There was 92% agreement between TTCE and TCDc for detecting right-to-left shunt.

    There were no immediate complications or new embolic adverse events within the 90 days after TCDc.

    "TCD is easy to use because of its portability and instantaneous interpretation," Dr. Khan said.

    "A direct cost comparison of echocardiogram and TCD has not been done," Dr. Khan added. "Therefore, it is difficult to compare the costs of the two procedures. However, given the nature of two procedures I suspect TCD to be cost-effective."

    By Will Boggs, MD

    Source: http://bit.ly/jrkJrI

    Stroke 2011;42:1473-1474.

    Last Updated: 2011-05-03 10:30:21 -0400 (Reuters Health)

    Copyright © 2011 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.


    || About || Advertising || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2013 || Education || Equipment Classifieds || Facebook || Forums || Home || Links || Marketplace || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2012 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2013 AuntMinnie.com. All Rights Reserved.